Kahn Clare 4
4 · Solid Biosciences Inc. · Filed Mar 4, 2021
Insider Transaction Report
Form 4
Kahn Clare
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-03-02+40,000→ 40,000 totalExercise: $10.72Exp: 2031-03-02→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]This option was granted on March 2, 2021 and vests in three equal annual installments on the anniversary of the grant date, subject to continued service as a director, and in the event of a change in control, the vesting schedule of the option will accelerate in full.